🔗 Share this article

This year's prestigious award in Physiology or Medicine has been awarded for transformative discoveries that clarify how the immune system targets dangerous pathogens while sparing the healthy tissues.

A trio of esteemed scientists—from Japan Prof. Sakaguchi and American experts Dr. Brunkow and Dr. Ramsdell—received this accolade.

Their work uncovered specialized "sentinels" within the defense system that remove malfunctioning defense cells that could harming the body.

The discoveries are now paving the way for innovative treatments for immune disorders and malignancies.

These winners will divide a monetary award valued at 11 million SEK.

Decisive Findings

"The work has been decisive for comprehending how the immune system functions and why we do not all suffer from severe self-attack conditions," commented the head of the award panel.

The team's studies address a core question: In what way does the immune system protect us from countless invaders while leaving our healthy cells intact?

The immune system uses white blood cells that search for signs of infection, even viruses and bacteria it has never encountered.

Such cells utilize sensors—known as recognition units—that are generated randomly in countless variations.

That provides the defense network the capacity to combat a broad range of invaders, but the unpredictability of the mechanism inevitably produces immune cells that may attack the body.

Protectors of the Immune System

Researchers previously knew that some of these problematic defense cells were destroyed in the thymus—the site where white blood cells develop.

The latest Nobel Prize honors the identification of regulatory T-cells—known as the body's "security guards"—which patrol the body to neutralize other defenders that attack the healthy cells.

It is known that this process malfunctions in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and RA.

A prize committee added, "The findings have established a new field of research and spurred the creation of new therapies, for instance for tumors and immune disorders."

In cancer, regulatory T-cells block the system from fighting the growth, so research are aimed at lowering their numbers.

In self-attack disorders, trials are testing increasing T-reg cells so the organism is no longer being harmed. A similar approach could also be useful in reducing the risks of transplanted organ failure.

Innovative Studies

Professor Shimon Sakaguchi, of a Japanese institution, performed experiments on mice that had their immune gland extracted, leading to self-attack conditions.

The researcher demonstrated that injecting defense cells from healthy animals could stop the disease—suggesting there was a system for preventing defenders from harming the body.

Mary Brunkow, from the a research center in a US city, and Dr. Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were investigating an inherited immune disorder in rodents and people that led to the discovery of a gene critical for the way regulatory T-cells function.

"The groundbreaking research has revealed how the immune system is kept in check by T-reg cells, stopping it from mistakenly attacking the body's own tissues," commented a prominent biological science specialist.

"The research is a striking illustration of how fundamental physiological study can have far-reaching consequences for public health."